The Venture Codex Logo

The Venture Codex

Overview

Manufacturing platform for cell and gene therapies.

Total Raised

$139 M

Rounds

3

Links

Verticals

Biotechnology
Industrial Automation
Manufacturing
Therapeutics

Investment History

  1. Series B

    Jan 2022

    $100M

  2. Series A

    Oct 2020

    $30M

  3. Seed

    Jan 2020

    $9M

Team

Jason C. Foster

CEO

Chris Mason

Founder & Director, Board of Directors

Farlan Veraitch

CSO

Thomas Heathman

Vice President of Commercial Operations